Qualitative Mutation Detection Kit for KRAS and NRAS Exons 2, 3, 4 - Vietnam Registration 2403585ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Qualitative Mutation Detection Kit for KRAS and NRAS Exons 2, 3, 4 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403585ĐKLH/BYT-HTTB and manufactured by Entrogen, Inc. The authorized representative in Vietnam is CÔNG TY TNHH CÔNG NGHỆ SINH HỌC MBS.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403585ĐKLH/BYT-HTTB
000.00.04.G18-240806-0009
CRCdx RAS Mutation Detection Kit
CRCDX-RAS
Technical Details
CRCdx RAS Mutation Detection Kit is an in vitro real-time PCR qualitative diagnostic test designed to detect 35 mutations of the KRAS and NRAS exon 2, 3, 4 in the DNA of the gene extracted from the formalin-fixed, paraffin-embedded (FFPE) tumor tissue sample of colorectal cancer (CRC). The test aims to provide a companion diagnostic (CDx) to assist in determining which patients with CRC may benefit from treatment with Vectibix® (panitumumab) based on the absence of a mutation as per the approved treatment product label. The CRCdx RAS test is performed on the QuantStudio™ Dx real-time PCR (QSDx) device to analyze the test and collect data. The data are analyzed using EntroGen’s PCR Analysis Software (EPAS™) to interpret the results.
Dates and Status
Nov 14, 2024